{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:21:53Z","timestamp":1777519313910,"version":"3.51.4"},"reference-count":21,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[1986,8,1]],"date-time":"1986-08-01T00:00:00Z","timestamp":523238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Psychiatry"],"published-print":{"date-parts":[[1986,8]]},"abstract":"<jats:p>Prevalence studies in Psychopharmacology are few and have many methodological flaws. This study examines the prevalence of psychoactive drugs in children and adolescents. Contrary to other studies, central nervous system stimulants are not the most widely prescribed psychoactive drugs in childhood and adolescence, but rather, minor tranquilizers, sedatives and hypnotics are the most widely prescribed psychoactive drugs. While this study overcomes some of the flaws of previous studies further studies regarding the prevalence of use of psychoactive drugs in childhood and adolescence are recommended.<\/jats:p>","DOI":"10.1177\/070674378603100616","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T04:31:08Z","timestamp":1493181068000},"page":"575-580","source":"Crossref","is-referenced-by-count":18,"title":["Prevalence of Psychoactive Medication in Children and Adolescents"],"prefix":"10.1177","volume":"31","author":[{"given":"Declan M.P.","family":"Quinn","sequence":"first","affiliation":[{"name":"Division of Child and Youth Psychiatry, Department of Psychiatry, University Hospital, Saskatoon, Saskatchewan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1986,8,1]]},"reference":[{"key":"bibr1-070674378603100616","doi-asserted-by":"publisher","DOI":"10.1037\/13306-000"},{"key":"bibr2-070674378603100616","volume-title":"Psychopharmacology in childhood and adolescence.","author":"Weiner J.M.","year":"1977"},{"key":"bibr3-070674378603100616","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(18)30951-1"},{"key":"bibr4-070674378603100616","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198404123101507"},{"key":"bibr5-070674378603100616","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1542\/peds.60.4.616","volume":"60","author":"Anders T.F.","year":"1977","journal-title":"Pediatrics"},{"key":"bibr6-070674378603100616","volume-title":"Pediatric psychopharmacology. A practical guide to clinical application.","author":"White J.H.","year":"1977"},{"key":"bibr7-070674378603100616","first-page":"13","volume":"37","author":"White J.H.","year":"1976","journal-title":"Psychiatry Digest"},{"key":"bibr8-070674378603100616","volume-title":"Hyperactive children: the social ecology of identification and treatment.","author":"Bosco J.J.","year":"1980"},{"key":"bibr9-070674378603100616","first-page":"20","author":"Henthoff N.","year":"1972","journal-title":"The Village Voice,"},{"issue":"6","key":"bibr10-070674378603100616","volume":"1","author":"Hunsinger S.","year":"1970","journal-title":"Christian Science Monitor"},{"key":"bibr11-070674378603100616","volume-title":"Psychosocial aspects of drug treatment for hyperactivity.","author":"Gadow K.D.","year":"1981"},{"key":"bibr12-070674378603100616","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1542\/peds.66.5.709","volume":"66","author":"Roush G.C.","year":"1980","journal-title":"Pediatrics"},{"key":"bibr13-070674378603100616","doi-asserted-by":"publisher","DOI":"10.1177\/070674378503000509"},{"key":"bibr14-070674378603100616","doi-asserted-by":"publisher","DOI":"10.1177\/070674378302800708"},{"key":"bibr15-070674378603100616","volume-title":"Handbook of biological psychiatry, Vol. 1, Part 6.","author":"Campbell M.","year":"1981"},{"issue":"4","key":"bibr16-070674378603100616","first-page":"20","volume":"38","author":"Krafchik B.R.","year":"1983","journal-title":"Atopic dermatitis: modern medicine of Canada"},{"key":"bibr17-070674378603100616","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.94.3.577"},{"key":"bibr18-070674378603100616","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7610.1977.tb00425.x"},{"key":"bibr19-070674378603100616","first-page":"291","volume":"21","author":"Gadow K.D.","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"bibr20-070674378603100616","doi-asserted-by":"publisher","DOI":"10.1111\/j.1746-1561.1979.tb07722.x"},{"key":"bibr21-070674378603100616","volume-title":"Psychosocial aspects of drug treatment for hyperactivity.","author":"Lambert N.M.","year":"1981"}],"container-title":["The Canadian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/070674378603100616","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/070674378603100616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:08:05Z","timestamp":1777392485000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.1177\/070674378603100616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,8]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1986,8]]}},"alternative-id":["10.1177\/070674378603100616"],"URL":"https:\/\/doi.org\/10.1177\/070674378603100616","relation":{},"ISSN":["0706-7437","1497-0015"],"issn-type":[{"value":"0706-7437","type":"print"},{"value":"1497-0015","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,8]]}}}